🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to determine how the organism affects MMF (met...
Status
Completed
Location
Almirall Investigational Site #1
Start Date
2016-09
Trial ID
NCT02955693
Treatments Being Tested
The purpose of this study was to understand whether participants could moun...
Status
Completed
Location
Novartis Investigative Site
Start Date
2021-04-19
Trial ID
NCT04792567
Treatments Being Tested
The investigators propose a multi-center pilot study, which aims to evaluat...
Status
Active Not Recruiting
Location
University of Colorado, Denver
Start Date
2023-03-07
Trial ID
NCT07757568
This clinical study compares the efficacy, safety, and tolerability of ther...
Status
Terminated
Location
UAB Dpt of Neurology
Start Date
2017-03-30
Trial ID
NCT02907177
Inflammatory synaptopathy is a prominent pathogenic process in multiple scl...
Status
Unknown
Location
IRCCS INM-Neuromed
Start Date
2023-07-26
Trial ID
NCT05779449
The primary objective of the study is to determine the effect of bismuth su...
Status
Completed
Location
Research Site
Start Date
2013-08
Trial ID
NCT01915901
To determine if treatment with BG00012 can decrease the number of MS relaps...
Status
Completed
Location
Research Site
Start Date
2007-06
Trial ID
NCT00451451
Treatments Being Tested
Coronavirus (Covid-19) has affected millions of people worldwide. Vaccines ...
Status
Active Not Recruiting
Location
University Hospitals of North Midlands NHS Trust
Start Date
2022-02-16
Trial ID
NCT05269888
Treatments Being Tested
Primary objective is to evaluate the immune response to vaccination with te...
Status
Completed
Location
Research Site
Start Date
2015-02-28
Trial ID
NCT02097849
The primary objective of the study is to determine whether a Medication Eve...
Status
Terminated
Location
Research Site
Start Date
2015-02-28
Trial ID
NCT02343159
Treatments Being Tested